InterVenn Biosciences

United States
Total Offices: 4
49 Total Employees
Year Founded: 2017
InterVenn Biosciences is a life sciences company using glycoproteomics and artificial intelligence to develop healthcare solutions. Its platform maps glycoprotein signals involved in disease progression, providing biological insights that genomics and proteomics alone may miss. The company applies this approach to women's health challenges such as ovarian cancer and endometriosis, with a vision of enabling earlier disease detection, more effective treatment, and more personalized patient care.

InterVenn Biosciences Offices

Hybrid Workspace

Employees engage in a combination of remote and on-site work.

Typical time on-site:
United States
Australia
Malaysia
Philippines